TrialMedicine2018

Maintenance of low disease activity and remission with etanercept-disease-modifying antirheumatic drug (DMARD) combination therapy compared with treatment with DMARDs alone in Latin American patients with active rheumatoid arthritis: Subset analysis of a randomized trial.

Cristiano A F Zerbini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.